COMPARISON OF TWO SALVAGE CHEMOTHERAPY REGIMENS BEFORE AUTOLOGOUS STEM CELL TRANSPLANTATION WITH OR WITHOUT MAINTENANCE RITUXIMAB IN TREATING PATIENTS WITH RELAPSED OR REFRACTORY AGGRESSIVE NON-HODGKIN'S LYMPHOMA: